Crossmark

Recurrence Incidence and Optimal Surveillance After Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendix Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-025-18203-x

Published Online: 2025-09-09

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kovalik, V. https://orcid.org/0000-0002-3921-7210
Sardi, A. https://orcid.org/0000-0003-4132-9489
King, M. C. https://orcid.org/0000-0002-3376-3827
Iugai, S. https://orcid.org/0009-0000-9778-4208
Falla-Zuniga, L. F. https://orcid.org/0000-0001-5065-1416
Uzhegova, K. https://orcid.org/0009-0007-8341-8558
Nieroda, C. https://orcid.org/0000-0002-6337-5278
Gushchin, V. https://orcid.org/0000-0002-6151-5660
License Information

Text and Data Mining valid from 2025-09-09

Version of Record valid from 2025-09-09
More Information

Article History

Received: 29 May 2025

Accepted: 10 August 2025

First Online: 9 September 2025

Ethical approval

: This cohort study was conducted using an institutional review board approved prospectively maintained database.

Document is current

Any future updates will be listed below